Spanish researchers design biomarkers for the detection of dengue and West Nile virus

This shows electrophoresis of DNA observed under ultraviolet light. Credit: Rekom Biotech - University of Granada

Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by the bite of a mosquito. These biomarkers can be used to identify these viral diseases, which affect millions of people worldwide.

The University of Granada spin-off Rekom Biotech is a biotech company composed of professionals from the private sector and from the University of Granada. Rekom Biotech is focused in the design and production of used in diagnostic tests called "recombinant antigents". These antigens are markers of a variety of diseases caused by viruses, bacteria, fungi and parasites.

Saving Lives and Money

These products can be used in the different in vitro diagnostic platforms or systems. Specifically, the designed at the University of Granada spin off "might serve to design diagnostic tests that will help save lives and money", states the Rekom Biotech general manager, Ana Camacho Páez.

The Andalusian company also supplies other services based on the design and production of proteins and other molecular biology tools.

Currently, Rekom Biotech supplies white label recombinant antigens to two American companies, and will start supplying biological material to a German company soon. Their catalogue includes more than 50 recombinant antigens for the in vitro diagnosis of a range of infectious diseases. This company conducts its R&D activities at the Health Technology Park in Granada, Spain.

Related Stories

Singapore scientists license lab-in-a-cartridge

date Feb 02, 2009

Rapid, easy and affordable tests for cancer and avian flu and other infectious diseases move a step closer to patients as DYAMED Biotech Pte Ltd licenses a unique all-in-one automated diagnostic system called MicroKit from ...

Manufacturing antibodies

date Mar 18, 2010

New antibodies and recombinant proteins with a key signaling role in immune response to disease have been produced through collaboration between molecular immunology institutes in the Czech Republic and Germany and a private ...

Recommended for you

Breathless: How blood-oxygen levels regulate air intake

date 5 hours ago

Researchers have unraveled the elusive process by which small, highly vascular clusters of sensory cells in the carotid arteries "taste the blood," as a 1926 essay put it—the initial step in regulating ...

Sex matters ... even for liver cells

date 6 hours ago

Female liver cells, and in particular those in menopaused women, are more susceptible to adverse effects of drugs than their male counterparts, according to new research carried out by the JRC. It is well ...

Caring for blindness: A new protein in sight?

date 7 hours ago

Vasoproliferative ocular diseases are responsible for sight loss in millions of people in the industrialised countries. Many patients do not currently respond to the treatment offered, which targets a specific ...

When genes are expressed in reverse

date 7 hours ago

Genes usually always be expressed as in Western writing: from left to right on the white canvas of our DNA. So when we speak of the activity of our genome, in fact we are referring to the expression of genes ...

Technique could speed biologic drugs

date 12 hours ago

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.